Investigating persistent villous atrophy in celiac disease patients on a strict gluten-free diet
Official title: Study of the Causes and Consequences of Persistent Villous Atrophy Despite an Intentionally Strict Gluten-free Diet in Celiac Disease Patients - Effect of an Ultra-strict Gluten-free Diet on Persistent Villous Atrophy
Run by Hospital Mutua de Terrassa · NCT06500754 · Data updated 2026-11-12
This study is trying to find out why some people with celiac disease still have gut problems even after sticking to a strict gluten-free diet for two years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 80 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Hospital Mutua de Terrassa Academic / other |
| Locations | 1 site (Terrassa, Barcelona) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | January 1, 2026 |
| Study ends | January 1, 2027 |
| Registry record updated | July 19, 2024 |
| Trial ID | NCT06500754 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults diagnosed with celiac disease who have been on a strict gluten-free diet for at least two years and show signs of persistent villous atrophy.
✕Probably not a fit
Patients with refractory celiac disease or other significant gastrointestinal disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on celiac disease patients who continue to experience villous atrophy despite adhering to a strict gluten-free diet for at least two years. It aims to identify the factors contributing to this persistent condition and its potential long-term complications. Participants will be monitored for their dietary adherence and serological responses, providing insights into the relationship between diet, microbiota, and epigenetics in celiac disease. The study seeks to enhance understanding of the clinical implications of ongoing villous atrophy in these patients.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for celiac disease patients who do not respond adequately to a gluten-free diet.
How similar studies have gone: While there have been studies on celiac disease and gluten-free diets, the specific focus on persistent villous atrophy in well-adhered patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age at diagnosis 18 years or more. * Diagnosis of CD with villous atrophy, positive serology and clinical and serological response to GFD. * To be in a GFD for at least 2 years, with good adherence to it. * Negative or positive anti-transglutaminase (tTG2) IgA antibodies at low titers (\<2 times the normal value) at recruitment. * Written informed consent. Exclusion Criteria: * Refractory CD (RCD) type 2 and type 1 * Other associated intestinal diseases (inflammatory bowel disease, microscopic colitis, other types of enteropathies). * Need for treatment with corticosteroids or immunosuppressants. * Surgeries or other diseases predisposing to bacterial overgrowth in the small intestine. * Pregnancy, lactation. * Associated chronic diseases (lung, heart, kidney, liver cirrhosis). * Alcoholism or drug addiction. * Schizophrenia-type psychiatric diseases, other psychoses, bipolar.
Where it's running
-
Hospital Universitari MútuaTerrassa
Terrassa, Barcelona, Spain Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mediterranean diet and processed food in adults with celiac disease on a gluten-free diet
This observational study looks at whether following a Mediterranean-style diet or eating more highly processed foods affects GI symptoms and quality of life in adults with celiac disease who have been on a strict gluten-free diet.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity
This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.
-
Omega-3 fats to reduce inflammation in adults with newly diagnosed celiac disease
This study tests whether adding omega-3 fatty acid supplements to a gluten-free plan helps reduce inflammation and promote intestinal healing in adults who have just been diagnosed with celiac disease.
-
Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease
This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.